Topics

High-grade gliomas | Treatment | Overview

Home > Publications > Topics > High-grade gliomas > Treatment > Overview

Swensen SN, Figuracion KCF, Venur VA, Emerson S, Tseng YD, Lo SS, Ermoian RP, Halasz LM.
Treatment Options for IDH-Mutant Malignant Gliomas.
Curr Treat Options Oncol. 2024 Nov 29. doi: 10.1007/s11864-024-01280-7. PMID: 39612163. Review˰ ˍ

Kampers LFC, Metselaar DS, Vinci M, Scirocchi F, Veldhuijzen van Zanten S, Eyrich M, Biassoni V, Hulleman E, Karremann M, Stücker W, Van Gool SW.
The Complexity of Malignant Glioma Treatment.
Cancers (Basel). 2025 Mar 4;17(5):879. doi: 10.3390/cancers17050879. PMID: 40075726. Review. ˍ

Jiang N, Xu LP, Li F, Wang PP, Cao Y.
Efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative chemotherapy treatment of multifocal high-grade glioma.
Front Oncol. 2025 Mar 24;15:1539362. doi: 10.3389/fonc.2025.1539362. PMID: 40196731. Observational study. ˍ

Jiang Z, Xu Y, Nie H, Xu B, Ji N, Zhao Z, Zhang W.
Evidence-based recommendations for adult high-grade glioma therapy: a critical appraisal of clinical practice guidelines.
Neurosurg Rev. 2025 Oct 13;48(1):698. doi: 10.1007/s10143-025-03885-4. PMID: 41081963. Guidelines˰ ˍ

Drappatz J, Mantica M.
Treatment strategies and innovation for recurrent high-grade glioma.
J Neurooncol. 2025 Dec 11;176(1):118. doi: 10.1007/s11060-025-05323-3. PMID: 41381983. Review˰ ˍ